comparemela.com

Latest Breaking News On - Athelon medical inc - Page 1 : comparemela.com

Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) Announces Pricing of $4.7 Million Public Offering

Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) Announces Pricing of $4.7 Million Public Offering
investorideas.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investorideas.com Daily Mail and Mail on Sunday newspapers.

New-york
United-states
Susan-noonan
Jim-frakes
Maxim-group
Athelon-medical-inc
Nasdaq
Drug-administration
Securities-exchange
Exchange-commission
Newswire-aethlon-medical-inc
Sa-noonan-communications

Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient Plasma

Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient Plasma
investorideas.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investorideas.com Daily Mail and Mail on Sunday newspapers.

Australia
India
Australian
James-frakes
Jim-frakes
Susan-noonan
Cellarcus-biosciences-inc
Athelon-medical-inc
Securities-exchange
Sa-noonan-communications
Exchange-commission
Aethlon-medical-inc

Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices

Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) Enters Into Materials Transfer Agreement for Santersus AG s NucleoCapture and HemoNucleoCapture Devices

Switzerland
London
City-of
United-kingdom
Zurich
Züsz
Swiss
James-frakes
Santersu-nucleocapture
Scott-maguire
Jim-frakes
Aethlon-hemopurifier

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.